Literature DB >> 16185299

Adenomatoid tumor of the adrenal gland: case report with immunohistochemical study.

Akihiko Hamamatsu1, Tomio Arai, Masao Iwamoto, Tomoyuki Kato, Motoji Sawabe.   

Abstract

Adrenal adenomatoid tumor (AT) is a recently recognized disease with marked male predominance. Herein is presented a case of adrenal AT incidentally found in a 30-year-old man and results of immunohistochemical examination of the tumor. The left adrenal gland, weighing 17 g, contained a mass measuring 3 x 2.5 x 2.5 cm in the cortical tissue. Cut surface showed a relatively well-circumscribed firm tumor with a white solid appearance. Histologically, the tumor had the typical appearance of AT described in the genital tract. Immunohistochemically, the tumor cells were positive for calretinin, D2-40, WT1, mesothelial cell antigen, CA125, thrombomodulin, vimentin and cytokeratins (stained by AE1 + AE3, OV-TL 12/30, CAM5.2 and MNF116), and negative for endothelial markers (CD31, CD34 and factor VIII-related antigen) and CD56. CD56-positive adrenocortical cells were diffusely scattered in the tumor, especially in its periphery. Immunohistochemistry of estrogen, progesterone and androgen receptors was negative. These findings confirm mesothelial origin of the tumor and suggest that this tumor has little relation to sex hormone despite male predominance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185299     DOI: 10.1111/j.1440-1827.2005.01887.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  9 in total

1.  Transmural peritoneal adenomatoid tumour in the ileocaecal region causing massive haemoperitoneum and low gastrointestinal bleeding: differential diagnosis with capillary haemangiomas.

Authors:  Jaime Ruiz-Tovar; Jair Santos; Alberto Lopez-Delgado; Albina Orduña; Rafael Calpena
Journal:  Ann R Coll Surg Engl       Date:  2011-05       Impact factor: 1.891

2.  Primary adrenal microcystic/reticular schwannoma: clinicopathological and immunohistochemical studies of an extremely rare case.

Authors:  Jun Zhou; Dandan Zhang; Guannan Wang; Wencai Li; Jingjing Xu; Yihui Ma; Jing Zhang; Zhen Li; Zhihua Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  A rare entity of an unusual site: adenomatoid tumour of the adrenal gland: a case report and review of the literature.

Authors:  H El-Daly; P Rao; F Palazzo; M Gudi
Journal:  Patholog Res Int       Date:  2010-06-15

4.  Significance of D2-40 expression in the diagnosis of gastrointestinal stromal tumor.

Authors:  Naoto Kuroda; Nobuyuki Tanida; Kazuhisa Oonishi; Kaori Inoue; Masahiko Ohara; Keiko Mizuno; Takahiro Taguchi; Yoshihiro Hayashi; Kazuhiro Hanazaki; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2008-07-01       Impact factor: 2.309

Review 5.  Cystic lymphangioma-like adenomatoid tumor of the adrenal gland: report of a rare case and review of the literature.

Authors:  Ming Zhao; Changshui Li; Jiangjiang Zheng; Minghui Yan; Ke Sun; Zhaoming Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15

6.  Adrenal adenomatoid tumor in a patient with human immunodeficiency virus.

Authors:  Roy Phitayakorn; Gregory Maclennan; Peter Sadow; Scott Wilhelm
Journal:  Rare Tumors       Date:  2011-04-04

7.  Adenomatoid Tumor of the Adrenal Gland in Young Woman: From Clinical and Radiological to Pathological Study.

Authors:  Brankica Krstevska; Sasha Jovanovska Mishevska; Rubens Jovanovic
Journal:  Rare Tumors       Date:  2016-12-07

8.  MR imaging features of peritoneal adenomatoid mesothelioma: a case report.

Authors:  Cynthia Maria Coelho Lins; Jorge Elias; Adilson Ferreira Cunha; Valdair Francisco Muglia; Carlos Ribeiro Monteiro; Fábio V Valeri; Omar Feres
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

Review 9.  Adenomatoid Tumor of the Adrenal Gland: Report of Two Cases and Review of the Literature.

Authors:  Jiexia Guan; Chang Zhao; Hengming Li; Wenjing Zhang; Weizhen Lin; Luying Tang; Jianning Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-23       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.